About SES-CAB: Science, Evidence & Safety Clinical Advisory Board
SES-CAB is an evidence-based pharmaceutical and therapeutics resource that helps patients, caregivers, and healthcare professionals find clear, reliable, and up-to-date guidance on medications, diseases, and supplements. We prioritize safety, clinical relevance, and transparency so users can make informed decisions in partnership with their healthcare providers.
Our Mission and Values
Our mission is to deliver trustworthy, actionable information on therapies and best practices grounded in current research. We uphold the values of scientific rigor, patient safety, clinical applicability, transparency, and continuous improvement.
What We Offer
Comprehensive Therapeutic Content
- Drug monographs: indications, dosing, contraindications, side effects, precautions, and monitoring
- Drug interactions: clinically relevant interactions with practical management guidance
- Disease guides: evidence-based treatment options and care considerations
- Supplement insights: safety, efficacy, and known interactions with medications
- Clinical pearls: risk mitigation, patient counseling points, and adherence strategies
Designed for Patients and Professionals
- Plain-language summaries for non-specialists
- Clinically oriented detail for healthcare professionals
- Clear references to levels of evidence and guideline-informed recommendations
How We Ensure Evidence Quality
Evidence Standards
- Priority to peer-reviewed research, clinical guidelines, and authoritative consensus statements
- Critical appraisal for study design, bias, applicability, and safety relevance
- Balanced presentation of benefits and risks with contextualized clinical relevance
Review Cadence
- Scheduled reviews to incorporate new approvals, safety communications, and guideline updates
- Rapid updates for safety alerts and clinically significant changes
Clinical Advisory Board
Our Clinical Advisory Board provides guidance on content priorities, clinical standards, and safety-focused best practices. The board draws on expertise across pharmacotherapy, primary care, and specialty practice, ensuring practical, patient-centered information. Advisory input helps maintain relevance and rigor while preserving editorial independence in final content decisions.
Editorial Policy and Review Process
- Content development by trained medical writers and pharmacists with subject-matter reviewers
- Multi-stage editorial review for accuracy, clarity, and consistency
- Conflict-of-interest checks and transparent sourcing practices
- Version control documenting updates and rationale for changes
Safety First
Safety is at the center of our work. We emphasize contraindications, high-risk populations, dose adjustments, monitoring parameters, and known interactions. Wherever applicable, we highlight practical steps to reduce harm, recognize adverse effects, and escalate care appropriately.
Transparency and Independence
- No promotion of therapies without evidence proportional to claimed benefit
- Clear separation between editorial content and any potential sponsorship, if present
- Disclosure of any relevant relationships or funding affecting content
Updates and Versioning
Each page undergoes periodic review. When updates occur, we document the date, scope, and reason for changes, especially for new approvals, boxed warnings, or revised guidelines.
Accessibility and Inclusion
We strive to make content accessible and understandable, using plain language where possible and offering structured summaries, definitions of key terms, and consistent formatting. We welcome feedback to improve accessibility and inclusivity for all users.
Privacy and Data Practices
SES-CAB is committed to responsible data practices. Any user data handling is designed to respect privacy, minimize collection, and protect information. We continually evaluate our processes to maintain high standards of confidentiality and security.
How to Use This Resource
- Start with a summary section to orient to the topic and key takeaways
- Review cautions and contraindications before therapy decisions
- Use dosing, interactions, and monitoring details to support clinical practice
- Discuss information with your healthcare provider for personalized care
Disclaimers
- Information on SES-CAB is educational and does not replace professional medical advice, diagnosis, or treatment
- Always consult a qualified healthcare professional for decisions about medications or treatments
- If you are experiencing a medical emergency, seek immediate emergency assistance
Ownership and Contact
SES-CAB is owned by Cheryl Moran.
Postal address: 2901 Los Feliz Blvd, Los Angeles, CA 90039, United States of America
Email: [email protected]
Feedback and Corrections
We encourage users to report inaccuracies, suggest improvements, or request new topics. Our team reviews all inquiries and, when appropriate, updates content with documented changes to maintain accuracy and relevance.